WuXi PharmaTech Cayman is a holding company. Through its subsidiaries, the Company is engaged in pharmaceutical, biotechnology and medical device research and development outsourcing, with operations in the People's Republic of China and the United States. The Company provides an integrated portfolio of laboratory and manufacturing services throughout the drug and medical device research and development process to the Company's customers, which include pharmaceutical, biotechnology and medical device companies. The Company conducts its operations in two segments: laboratory services and manufacturing services.
Data provided by Mergent, Inc.
Powered by Interactive Data Managed Solutions
Data provided by Thomson Reuters, Inc.
| DR Price Date | DR Price USD | US / Non-US / Total DRs | US / Non-US / Total DR Capital Raised USD |
|---|---|---|---|
| Aug 14, 2007 | 14.00 |
15,167,326
0 15,167,326 |
212,342,564
0 212,342,564 |
| DR Symbol | WX |
| CUSIP | 929352102 |
| DR Exchange | New York Stock Exchange |
| DR ISIN | US9293521020 |
| Ratio | 1:8 |
| Depositary | JPMC (Sponsored) |
| Effective Date | Aug 14, 2007 |
| Local Exchange | Not Traded |
| Country | China |
| Industry | Pharma. & Biotech. |
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
Apr. 13 |
19.07 | 7,701,554 | 350,071 |
Mar. 13 |
17.18 | 6,626,002 | 331,300 |
Feb. 13 |
16.34 | 3,748,814 | 197,306 |
This DR is a Constituent of the following BNY Mellon DR Indices:
|
Related links |
Helpful Links |